Form 4: scPharmaceuticals Director Acquires Stock Options

Leonard D. Schaeffer, a director of scPharmaceuticals Inc., acquired stock options for 19,750 shares on June 11, 2024.

Summary

• On June 11, 2024, Leonard D. Schaeffer, a director of scPharmaceuticals Inc., acquired stock options for 19,750 shares.
• The exercise price of these options is $4.11.
• The options vest fully on the earlier of June 11, 2025, or the next annual meeting of the Issuer's stockholders.
• The options expire on June 11, 2034.
• Following the transaction, Schaeffer directly owns 19,750 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in the pharmaceutical industry. Monitoring such filings can provide insights into management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The acquisition of stock options by a director could be perceived positively by shareholders, as it aligns the director's interests with those of the shareholders.

Key Dates